- Issue: Blood clots and other dangerous side effects
Yaz Lawsuits and Settlements - 2014 Update
Serious side effects have been linked to the birth control drugs Yaz and Yasmin, and their generic versions Gianvi and Ocella. These side effects include strokes, heart attacks and blood clots that form inside a vein, known as deep vein thrombosis. The blood clots usually start in the lower leg or thigh. If they break loose, the blood clots can travel to other areas of the body such as the lungs and become life threatening if undetected or untreated.
To date, Bayer, the manufacturer of Yaz, Yasmin, Gianvi and Ocella, has announced settlements of 7,660 claims – totaling $1.6 billion - in the Yaz birth control lawsuits.
Yaz Lawsuits Summarized
Prescription drug companies owe a duty to patients to sell prescription drugs that are safe and effective, and fully disclose the risks associated with their drugs.
Our clients charge that Bayer failed to comply with this duty. Bayer was aware of the greater risk of blood clots from Yaz and Yasmin compared to other birth control drugs, and failed to adequately warn patients and physicians of this risk, the lawsuits charge.
Contact a Yaz Lawyer | Yasmin Attorney: Free Case Review
Lieff Cabraser represents women across America injured by Yaz, as well as families of loved ones who died. We have a team of experienced female personal attorneys assigned to the Yaz litigation. We have successfully negotiated many confidential settlements with Bayer. Please use the form below to contact Lieff Cabraser for a free, prompt and confidential evaluation of your case. Or call us toll-free at 1-888-321-1510 and ask to speak to attorney Paulina do Amaral.
We handle all inquiries with the strictest confidentiality and sensitivity. There is no charge or obligation for our review of your claim.
Yaz and Yasmin are registered trademarks of Bayer Schering Pharma Aktiengesellschaft. Ocella is a registered trademark of Barr Laboratories, Inc. The use of these trademarks is solely for informational and product identification purposes. Nothing on this site has been authorized or approved by Bayer Schering Pharma Aktiengesellschaft or Barr Laboratories, Inc.